Top compounds associated with response to WLS


Feature Type Standardized
Nominal ANOVA
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.012 0.7
mRNA SB590885 GDSC1000 pan-cancer AAC -0.014 0.7
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.011 0.7
mRNA Erlotinib CCLE pan-cancer AAC -0.02 0.7
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Gemcitabine GDSC1000 pan-cancer AAC 0.015 0.7
mRNA AR-42 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA MS-275 GDSC1000 pan-cancer AAC 0.026 0.7
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.017 0.7
mRNA MP470 GDSC1000 pan-cancer AAC 0.014 0.7
Download CSV